Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 25 May 2022


The time is now: How to restore Europe’s leading position in pharma innovation

Hubertus von Baumbach (Boehringer Ingelheim) for POLITICO

Recent crises have highlighted the critical need for Europe to secure and strengthen its position as leader in medical innovation. As the European Commission works on the review of the Pharmaceutical Regulation, we need to ensure Europe has the right environment to bring the next generation of treatments to patients. The challenge for the coming decades is not if medical innovation will happen but where it will happen.

This article is part of a series explaining that where innovation happens matters for patients, health care systems, the research community, jobs and the economy.

Read more




RETHINKING Alzheimer’s disease project, calling for change in Alzheimer’s care, kicks off!
24 May 2022

Now is the time to rethink Alzheimer’s disease to improve Alzheimer’s disease care pathway and the lives of people living... Read more


Innovative Clinical Trials

"Patients with unmet needs are longing for innovative treatments to be approved. Especially rare disease patients, where only 5-6% have approved treatments, need a new strategy to speed up research and provide new opportunities to access innovative drugs. Complex clinical trials can be the change that patients want to see".
Claas Röhl, chairman of NF Patients United


Better fit research into patients' lives
"New trials enable participants to continue with their day-to-day lives with minimal disruption", says Jenny Camaradou,... Read more

Unlocking new benefits for patients & medical research
"Ambitions are high, and it’s not always easy, but #WeWontRest until we get to the innovative design that improves and... Read more


EFPIA Conference | Save the Date | Brussels & Online


Recently published


Shortening the WAIT - Patient Access to Medicines in Europe
06 April 2022 (News & Events)

Disparities in the time it takes for patients to access new medicines in different EU Member States are increasing. Read more

New proposals from the research-based pharmaceutical industry should reduce inequalities in...
11 April 2022 (News & Events)

Europe's pharmaceutical sector is stepping up measures to help deliver faster, more equitable access to medicines for... Read more

Are medicines affordable for health systems? The myths, the facts and the way forward
07 April 2022 (News & Events)

Pharmaceutical expenditure has been stable as a share of total healthcare expenditure in all European countries included... Read more


What we are reading


Early signs support revolutionary potential of EU clinical trials regulation
On 23 May 2022 (

Featuring Silvia Garcia, Senior Manager, Regulatory, Drug Development and Manufacturing at EFPIA. Read more

Working At The Speed Of Science And Why You Should Be Excited
On 13 May 2022 (IFLS)

During the COVID-19 pandemic, pharmaceutical companies and researchers around the world raced to develop a vaccine. Read more